NHWD-840
- Generic Name
- NHWD-840
A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Zhejiang Wenda Medical Technology Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT06527300
- Locations
- 🇨🇳
Three Gorges Hospital Affiliated to Chongqing University, Chongqing, China
Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement
Recruiting
- Conditions
- Advanced Solid Tumors or Lymphomas
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- Hunan Province Tumor Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06073938
- Locations
- 🇨🇳
Hunan Provincal Tumor Hospital, Changsha, Hunan, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath